TY - JOUR A1 - El-Helou, Sabine M. A1 - Biegner, Anika-Kerstin A1 - Bode, Sebastian A1 - Ehl, Stephan R. A1 - Heeg, Maximilian A1 - Maccari, Maria E. A1 - Ritterbusch, Henrike A1 - Speckmann, Carsten A1 - Rusch, Stephan A1 - Scheible, Raphael A1 - Warnatz, Klaus A1 - Atschekzei, Faranaz A1 - Beider, Renata A1 - Ernst, Diana A1 - Gerschmann, Stev A1 - Jablonka, Alexandra A1 - Mielke, Gudrun A1 - Schmidt, Reinhold E. A1 - Schürmann, Gesine A1 - Sogkas, Georgios A1 - Baumann, Ulrich H. A1 - Klemann, Christian A1 - Viemann, Dorothee A1 - Bernuth, Horst von A1 - Krüger, Renate A1 - Hanitsch, Leif G. A1 - Scheibenbogen, Carmen M. A1 - Wittke, Kirsten A1 - Albert, Michael H. A1 - Eichinger, Anna A1 - Hauck, Fabian A1 - Klein, Christoph A1 - Rack-Hoch, Anita A1 - Sollinger, Franz M. A1 - Avila, Anne A1 - Borte, Michael A1 - Borte, Stephan A1 - Fasshauer, Maria A1 - Hauenherm, Anja A1 - Kellner, Nils A1 - Müller, Anna H. A1 - Ülzen, Anett A1 - Bader, Peter A1 - Bakhtiar, Shahrzad A1 - Lee, Jae-Yun A1 - Heß, Ursula A1 - Schubert, Ralf A1 - Wölke, Sandra A1 - Zielen, Stefan A1 - Ghosh, Sujal A1 - Laws, Hans-Juergen A1 - Neubert, Jennifer A1 - Oommen, Prasad T. A1 - Hönig, Manfred A1 - Schulz, Ansgar A1 - Steinmann, Sandra A1 - Klaus, Schwarz A1 - Dückers, Gregor A1 - Lamers, Beate A1 - Langemeyer, Vanessa A1 - Niehues, Tim A1 - Shai, Sonu A1 - Graf, Dagmar A1 - Müglich, Carmen A1 - Schmalzing, Marc T. A1 - Schwaneck, Eva C. A1 - Tony, Hans-Peter A1 - Dirks, Johannes A1 - Haase, Gabriele A1 - Liese, Johannes G. A1 - Morbach, Henner A1 - Foell, Dirk A1 - Hellige, Antje A1 - Wittkowski, Helmut A1 - Masjosthusmann, Katja A1 - Mohr, Michael A1 - Geberzahn, Linda A1 - Hedrich, Christian M. A1 - Müller, Christiane A1 - Rösen-Wolff, Angela A1 - Roesler, Joachim A1 - Zimmermann, Antje A1 - Behrends, Uta A1 - Rieber, Nikolaus A1 - Schauer, Uwe A1 - Handgretinger, Rupert A1 - Holzer, Ursula A1 - Henes, Jörg A1 - Kanz, Lothar A1 - Boesecke, Christoph A1 - Rockstroh, Jürgen K. A1 - Schwarze-Zander, Carolynne A1 - Wasmuth, Jan-Christian A1 - Dilloo, Dagmar A1 - Hülsmann, Brigitte A1 - Schönberger, Stefan A1 - Schreiber, Stefan A1 - Zeuner, Rainald A1 - Ankermann, Tobias A1 - Bismarck, Philipp von A1 - Huppertz, Hans-Iko A1 - Kaiser-Labusch, Petra A1 - Greil, Johann A1 - Jakoby, Donate A1 - Kulozik, Andreas E. A1 - Metzler, Markus A1 - Naumann-Bartsch, Nora A1 - Sobik, Bettina A1 - Graf, Norbert A1 - Heine, Sabine A1 - Kobbe, Robin A1 - Lehmberg, Kai A1 - Müller, Ingo A1 - Herrmann, Friedrich A1 - Horneff, Gerd A1 - Klein, Ariane A1 - Peitz, Joachim A1 - Schmidt, Nadine A1 - Bielack, Stefan A1 - Groß-Wieltsch, Ute A1 - Classen, Carl F. A1 - Klasen, Jessica A1 - Deutz, Peter A1 - Kamitz, Dirk A1 - Lassy, Lisa A1 - Tenbrock, Klaus A1 - Wagner, Norbert A1 - Bernbeck, Benedikt A1 - Brummel, Bastian A1 - Lara-Villacanas, Eusebia A1 - Münstermann, Esther A1 - Schneider, Dominik T. A1 - Tietsch, Nadine A1 - Westkemper, Marco A1 - Weiß, Michael A1 - Kramm, Christof A1 - Kühnle, Ingrid A1 - Kullmann, Silke A1 - Girschick, Hermann A1 - Specker, Christof A1 - Vinnemeier-Laubenthal, Elisabeth A1 - Haenicke, Henriette A1 - Schulz, Claudia A1 - Schweigerer, Lothar A1 - Müller, Thomas G. A1 - Stiefel, Martina A1 - Belohradsky, Bernd H. A1 - Soetedjo, Veronika A1 - Kindle, Gerhard A1 - Grimbacher, Bodo T1 - The German national registry of primary immunodeficiencies (2012-2017) JF - Frontiers in Immunology N2 - Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment. KW - registry for primary immunodeficiency KW - primary immunodeficiency (PID) KW - German PID-NET registry KW - PID prevalence KW - European Society for Immunodeficiencies (ESID) KW - IgG substitution therapy KW - CVID Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-226629 VL - 10 ER - TY - JOUR A1 - Temme, Fabian A1 - Adam, Jan A1 - Ahnen, Max L. A1 - Baack, Dominik A1 - Balbo, Matteo A1 - Bergmann, Matthias A1 - Biland, Adrian A1 - Blank, Michael A1 - Bretz, Thomas A1 - Brügge, Kai A. A1 - Buss, Jens A1 - Dmytriiev, Anton A1 - Dorner, Daniela A1 - Einecke, Sabrina A1 - Hempfling, Christina A1 - Hildebrand, Dorothee A1 - Hughes, Gareth A1 - Linhoff, Lena A1 - Mannheim, Karl A1 - Müller, Sebastian A1 - Neise, Dominik A1 - Neronov, Andrii A1 - Nöthe, Max A1 - Paravac, Aleksander A1 - Pauss, Felicitas A1 - Rhode, Wolfgang A1 - Shukla, Amit A1 - Thaele, Julia A1 - Walter, Roland T1 - Long-Term monitoring of bright blazars in the multi-GeV to TeV range with FACT JF - Galaxies N2 - Blazars like Markarian 421 or Markarian 501 are active galactic nuclei (AGN), with their jets orientated towards the observer. They are among the brightest objects in the very high energy (VHE) gamma ray regime (>100 GeV). Their emitted gamma-ray fluxes are extremely variable, with changing activity levels on timescales between minutes, months, and even years. Several questions are part of the current research, such as the question of the emission regions or the engine of the AGN and the particle acceleration. A dedicated longterm monitoring program is necessary to investigate the properties of blazars in detail. A densely sampled and unbiased light curve allows for observation of both high and low states of the sources, and the combination with multi-wavelength observation could contribute to the answer of several questions mentioned above. FACT (First G-APD Cherenkov Telescope) is the first operational telescope using silicon photomultiplier (SiPM, also known as Geigermode—Avalanche Photo Diode, G-APD) as photon detectors. SiPM have a very homogenous and stable longterm performance, and allow operation even during full moon without any filter, leading to a maximal duty cycle for an Imaging Air Cherenkov Telescope (IACT). Hence, FACT is an ideal device for such a longterm monitoring of bright blazars. A small set of sources (e.g., Markarian 421, Markarian 501, 1ES 1959+650, and 1ES 2344+51.4) is currently being monitored. In this contribution, the FACT telescope and the concept of longterm monitoring of bright blazars will be introduced. The results of the monitoring program will be shown, and the advantages of densely sampled and unbiased light curves will be discussed. KW - Imaging Air Cherenkov Telescope KW - First G-APD Cherenkov Telescope KW - very high energy gamma rays KW - long-term monitoring KW - silicon photo multiplier Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-198088 SN - 2075-4434 VL - 5 IS - 1 PB - MDPI ER - TY - JOUR A1 - Proetel, Ulrike A1 - Pletsch, Nadine A1 - Lauseker, Michael A1 - Müller, Martin C. A1 - Hanfstein, Benjamin A1 - Krause, Stefan W. A1 - Kalmanti, Lida A1 - Schreiber, Annette A1 - Heim, Dominik A1 - Baerlocher, Gabriela M. A1 - Hofmann, Wolf-Karsten A1 - Lange, Elisabeth A1 - Einsele, Hermann A1 - Wernli, Martin A1 - Kremers, Stephan A1 - Schlag, Rudolf A1 - Müller, Lothar A1 - Hänel, Mathias A1 - Link, Hartmut A1 - Hertenstein, Bernd A1 - Pfirrmann, Markus A1 - Hochhaus, Andreas A1 - Hasford, Joerg A1 - Hehlmann, Rüdiger A1 - Saußele, Susanne T1 - Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV JF - Annals of Hematology N2 - The impact of imatinib dose on response rates and survival in older patients with chronic myeloid leukemia in chronic phase has not been studied well. We analyzed data from the German CML-Study IV, a randomized five-arm treatment optimization study in newly diagnosed BCR-ABL-positive chronic myeloid leukemia in chronic phase. Patients randomized to imatinib 400 mg/day (IM400) or imatinib 800 mg/day (IM800) and stratified according to age (≥65 years vs. <65 years) were compared regarding dose, response, adverse events, rates of progression, and survival. The full 800 mg dose was given after a 6-week run-in period with imatinib 400 mg/day. The dose could then be reduced according to tolerability. A total of 828 patients were randomized to IM400 or IM800. Seven hundred eighty-four patients were evaluable (IM400, 382; IM800, 402). One hundred ten patients (29 %) on IM400 and 83 (21 %) on IM800 were ≥65 years. The median dose per day was lower for patients ≥65 years on IM800, with the highest median dose in the first year (466 mg/day for patients ≥65 years vs. 630 mg/day for patients <65 years). Older patients on IM800 achieved major molecular remission and deep molecular remission as fast as younger patients, in contrast to standard dose imatinib with which older patients achieved remissions much later than younger patients. Grades 3 and 4 adverse events were similar in both age groups. Five-year relative survival for older patients was comparable to that of younger patients. We suggest that the optimal dose for older patients is higher than 400 mg/day. ClinicalTrials.gov identifier: NCT00055874 KW - chronic myeloid leukemia KW - older patients KW - different imatinib dose regimens KW - early applied higher imatinib dosages Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-121574 SN - 0939-5555 VL - 93 IS - 7 ER - TY - JOUR A1 - Opolka, Alexander A1 - Müller, Dominik A1 - Fella, Christian A1 - Balles, Andreas A1 - Mohr, Jürgen A1 - Last, Arndt T1 - Multi-lens array full-field X-ray microscopy JF - Applied Sciences N2 - X-ray full-field microscopy at laboratory sources for photon energies above 10 keV suffers from either long exposure times or low resolution. The photon flux is mainly limited by the objectives used, having a limited numerical aperture NA. We show that this can be overcome by making use of the cone-beam illumination of laboratory sources by imaging the same field of view (FoV) several times under slightly different angles using an array of X-ray lenses. Using this technique, the exposure time can be reduced drastically without any loss in terms of resolution. A proof-of-principle is given using an existing laboratory metal-jet source at the 9.25 keV Ga K\(_α\)-line and compared to a ray-tracing simulation of the setup. KW - X-ray microscopy KW - full-field microscopy KW - compound refractive X-ray lenses KW - CRLs Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-244974 SN - 2076-3417 VL - 11 IS - 16 ER - TY - RPRT A1 - Müller, Jörg A1 - Scherer-Lorenzen, Michael A1 - Ammer, Christian A1 - Eisenhauer, Nico A1 - Seidel, Dominik A1 - Schuldt, Bernhard A1 - Biedermann, Peter A1 - Schmitt, Thomas A1 - Künzer, Claudia A1 - Wegmann, Martin A1 - Cesarz, Simone A1 - Peters, Marcell A1 - Feldhaar, Heike A1 - Steffan-Dewenter, Ingolf A1 - Claßen, Alice A1 - Bässler, Claus A1 - von Oheimb, Goddert A1 - Fichtner, Andreas A1 - Thorn, Simon A1 - Weisser, Wolfgang T1 - BETA-FOR: Erhöhung der strukturellen Diversität zwischen Waldbeständen zur Erhöhung der Multidiversität und Multifunktionalität in Produktionswäldern. Antragstext für die DFG Forschungsgruppe FOR 5375 T1 - BETA-FOR: Enhancing the structural diversity between patches for improving multidiversity and multifunctionality in production forests. Proposal for DFG Research Unit FOR 5375 BT - β\(_4\) : Proposal for the 1st phase (2022-2026) of the DFG Research Unit FOR 5375/1 (DFG Forschergruppe FOR 5375/1 – BETA-FOR), Fabrikschleichach, October 2021 N2 - Der in jüngster Zeit beobachtete kontinuierliche Verlust der β-Diversität in Ökosystemen deutet auf homogene Gemeinschaften auf Landschaftsebene hin, was hauptsächlich auf die steigende Landnutzungsintensität zurückgeführt wird. Biologische Vielfalt ist mit zahlreichen Funktionen und der Stabilität von Ökosystemen verknüpft. Es ist daher zu erwarten, dass eine abnehmende β-Diversität auch die Multifunktionalität verringert. Wir kombinieren hier Fachwissen aus der Forstwissenschaft, der Ökologie, der Fernerkundung, der chemischen Ökologie und der Statistik in einem gemeinschaftlichen und experimentellen β-Diversitätsdesign, um einerseits die Auswirkungen der Homogenisierung zu bewerten und andererseits Konzepte zu entwickeln, um negative Auswirkungen durch Homogenisierung in Wäldern rückgängig zu machen. Konkret werden wir uns mit der Frage beschäftigen, ob die Verbesserung der strukturellen β-Komplexität (ESBC) in Wäldern durch Waldbau oder natürliche Störungen die Biodiversität und Multifunktionalität in ehemals homogenen Produktionswäldern erhöhen kann. Unser Ansatz wird mögliche Mechanismen hinter den beobachteten Homogenisierungs-Diversitäts-Beziehungen identifizieren und zeigen, wie sich diese auf die Multifunktionalität auswirken. An elf Standorten in ganz Deutschland haben wir dazu zwei Waldbestände als zwei kleine "Waldlandschaften" ausgewählt. In einem dieser beiden Bestände haben wir ESBC (Enhancement of Structural Beta Complexity)-Behandlungen durchgeführt. Im zweiten, dem Kontrollbestand, werden wir die gleich Anzahl 50x50m Parzellen ohne ESBC einrichten. Auf allen Parzellen werden wir 18 taxonomische Artengruppen aller trophischer Ebenen und 21 Ökosystemfunktionen, einschließlich der wichtigsten Funktionen in Wäldern der gemäßigten Zonen, messen. Der statistische Rahmen wird eine umfassende Analyse der Biodiversität ermöglichen, indem verschiedenen Aspekte (taxonomische, funktionelle und phylogenetische Vielfalt) auf verschiedenen Skalenebenen (α-, β-, γ-Diversität) quantifiziert werden. Um die Gesamtdiversität zu kombinieren, werden wir das Konzept der Multidiversität auf die 18 Taxa anwenden. Wir werden neue Ansätze zur Quantifizierung und Aufteilung der Multifunktionalität auf α- und β-Skalen verwenden und entwickeln. Durch die experimentelle Beschreibung des Zusammenhangs zwischen β-Diversität und Multifunktionalität in einer Reallandschaft wird unsere Forschung einen neuen Weg einschlagen. Darüber hinaus werden wir dazu beitragen, verbesserte Leitlinien für waldbauliche Konzepte und für das Management natürlicher Störungen zu entwickeln, um Homogenisierungseffekte der Vergangenheit umzukehren. N2 - The recently observed consistent loss of β-diversity across ecosystems indicates increasingly homogeneous communities in patches of landscapes, mainly caused by increasing land-use intensity. Biodiversity is related to numerous ecosystem functions and stability. Therefore, decreasing β-diversity is also expected to reduce multifunctionality. To assess the impact of homogenization and to develop guidelines to reverse its potentially negative effects, we combine expertise from forest science, ecology, remote sensing, chemical ecology and statistics in a collaborative and experimental β-diversity approach. Specifically, we will address the question whether the Enhancement of Structural Beta Complexity (ESBC) in forests by silviculture or natural disturbances will increase biodiversity and multifunctionality in formerly homogeneously structured production forests. Our approach will identify potential mechanisms behind observed homogenization-diversity-relationships and show how these translate into effects on multifunctionality. At eleven forest sites throughout Germany, we selected two districts as two types of small ‘forest landscapes’. In one of these two districts, we established ESBC treatments (nine differently treated 50x50 m patches with a focus on canopy cover and deadwood features). In the second, the control district, we will establish nine patches without ESBC. By a comprehensive sampling, we will monitor 18 taxonomic groups and measure 21 ecosystem functions, including key functions in temperate forests, on all patches. The statistical framework will allow a comprehensive biodiversity assessment by quantifying the different aspects of multitrophic biodiversity (taxonomical, functional and phylogenetic diversity) on different levels of biodiversity (α-, β-, γ-diversity). To combine overall diversity, we will apply the concept of multidiversity across the 18 taxa. We will use and develop new approaches for quantification and partitioning of multifunctionality at α- and β- scales. Overall, our study will herald a new research avenue, namely by experimentally describing the link between β-diversity and multifunctionality. Furthermore, we will help to develop guidelines for improved silvicultural concepts and concepts for management of natural disturbances in temperate forests reversing past homogenization effects. KW - Waldökosystem KW - Biodiversität KW - BETA-Multifunktionalität KW - beta-multifunctionality KW - BETA-Diversität KW - beta diversity KW - Forschungsstation Fabrikschleichach Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-290849 ER - TY - THES A1 - Müller, Dominik Dennis T1 - Laborbasierte Nano-Computertomographie mit hoher Energie für die Materialcharakterisierung und Halbleiterprüfung in Simulation und Anwendung T1 - Laboratory Based Nano Computed Tomography with Higher Photon Energy for Materials Characterization and Semiconductor Analysis in Simulation and Practical Application N2 - Verschiedene Konzepte der Röntgenmikroskopie haben sich mittlerweile im Labor etabliert und ermöglichen heute aufschlussreiche Einblicke in eine Vielzahl von Probensystemen. Der „Labormaßstab“ bezieht sich dabei auf Analysemethoden, die in Form von einem eigenständigen Gerät betrieben werden können. Insbesondere sind sie unabhängig von der Strahlerzeugung an einer Synchrotron-Großforschungseinrichtung und einem sonst kilometergroßen Elektronen-speicherring. Viele der technischen Innovationen im Labor sind dabei ein Transfer der am Synchrotron entwickelten Techniken. Andere wiederum basieren auf der konsequenten Weiterentwicklung etablierter Konzepte. Die Auflösung allein ist dabei nicht entscheidend für die spezifische Eignung eines Mikroskopiesystems im Ganzen. Ebenfalls sollte das zur Abbildung eingesetzte Energiespektrum auf das Probensystem abgestimmt sein. Zudem muss eine Tomographieanalage zusätzlich in der Lage sein, die Abbildungsleistung bei 3D-Aufnahmen zu konservieren. Nach einem Überblick über verschiedene Techniken der Röntgenmikroskopie konzentriert sich die vorliegende Arbeit auf quellbasierte Nano-CT in Projektionsvergrößerung als vielversprechende Technologie zur Materialanalyse. Hier können höhere Photonenenergien als bei konkurrierenden Ansätzen genutzt werden, wie sie von stärker absorbierenden Proben, z. B. mit einem hohen Anteil von Metallen, zur Untersuchung benötigt werden. Das bei einem ansonsten idealen CT-Gerät auflösungs- und leistungsbegrenzende Bauteil ist die verwendete Röntgen-quelle. Durch konstruktive Innovationen sind hier die größten Leistungssprünge zu erwarten. In diesem Zuge wird erörtert, ob die Brillanz ein geeignetes Maß ist, um die Leistungsfähigkeit von Röntgenquellen zu evaluieren, welchen Schwierigkeiten die praktische Messung unterliegt und wie das die Vergleichbarkeit der Werte beeinflusst. Anhand von Monte-Carlo-Simulationen wird gezeigt, wie die Brillanz verschiedener Konstruktionen an Röntgenquellen theoretisch bestimmt und miteinander verglichen werden kann. Dies wird am Beispiel von drei modernen Konzepten von Röntgenquellen demonstriert, welche zur Mikroskopie eingesetzt werden können. Im Weiteren beschäftigt sich diese Arbeit mit den Grenzen der Leistungsfähigkeit von Transmissionsröntgenquellen. Anhand der verzahnten Simulation einer Nanofokus-Röntgenquelle auf Basis von Monte-Carlo und FEM-Methoden wird untersucht, ob etablierte Literatur¬modelle auf die modernen Quell-konstruktionen noch anwendbar sind. Aus den Simulationen wird dann ein neuer Weg abgeleitet, wie die Leistungsgrenzen für Nanofokus-Röntgenquellen bestimmt werden können und welchen Vorteil moderne strukturierte Targets dabei bieten. Schließlich wird die Konstruktion eines neuen Nano-CT-Gerätes im Labor-maßstab auf Basis der zuvor theoretisch besprochenen Nanofokus-Röntgenquelle und Projektionsvergrößerung gezeigt, sowie auf ihre Leistungsfähigkeit validiert. Es ist spezifisch darauf konzipiert, hochauflösende Messungen an Materialsystemen in 3D zu ermöglichen, welche mit bisherigen Methoden limitiert durch mangelnde Auflösung oder Energie nicht umsetzbar waren. Daher wird die praktische Leistung des Gerätes an realen Proben und Fragestellungen aus der Material¬wissenschaft und Halbleiterprüfung validiert. Speziell die gezeigten Messungen von Fehlern in Mikrochips aus dem Automobilbereich waren in dieser Art zuvor nicht möglich. N2 - Various concepts of X-ray microscopy have become established in laboratories. Nowadays, they allow insightful analysis of a wide range of sample systems. In this context, "laboratory scale" refers to the analytical methods that operate as a stand-alone instrument. They are independent from beam generation at a large-scale synchrotron research facility with a kilometer-sized electron storage ring. Many of the technical innovations in the laboratory are transferred techniques developed at the synchrotron. Others are based on the continuous further development of previously established concepts. By itself, resolution is not decisive for the specific suitability of a microscopy system in general. The energy spectrum used for imaging should also be matched to the specimen and a tomography system must be able to preserve the imaging performance for 3D images. After an overview of different X-ray microscopy techniques, this work examines how source-based nano-CT in projection magnification is a promising technology for materials analysis. Here, higher photon energies can be used than in competing approaches as required by more absorbent samples for examination, such as those with a high metal content. The core component limiting resolution and performance in an otherwise ideal CT device is the X-ray source used. The greatest leaps in imaging performance can be expected through design innovations in the X ray source. Therefore, In the course of this work, it is discussed when brilliance is and is not an appropriate measure to evaluate the performance of X-ray sources, what difficulties practical measurement is subject to and how this affects the comparability of values. Monte Carlo simulations show how the brilliance of different designs on X-ray sources can be theoretically determined and compared, and this is demonstrated by the example of three modern concepts of X-ray sources, which can be used for microscopy. Next, this thesis considers the limits of the performance of transmission X-ray sources. Using the coupled simulation of a nano focus X-ray source based on Monte Carlo and FEM methods, this thesis investigates whether established literature models are still applicable to these modern source designs. The simulations are then used to derive a new way to determine the performance limits for nano focus X-ray sources and the advantage of modern targets made of multiple layers. Then, a new laboratory-scale nano-CT device based on the nano focus X-ray source and projection magnification is theoretically discussed before it is presented with an evaluation of its performance. It is specifically designed to enable high-resolution measurements on material systems in 3D, which were not feasible with previous methods as they were limited by a lack of resolution or energy. Therefore, the practical performance of the device can finally be validated on real samples and issues from materials science and semiconductor inspection. The shown measurements of defects in automotive microchips in this way were not previously possible. KW - Computertomografie KW - Röntgenquelle KW - Mikroelektronik KW - Simulation KW - Nano-CT KW - Röntgenquellen KW - Materialuntersuchung KW - Geräteentwicklung KW - High Resolution KW - Monte-Carlo KW - Semiconductor KW - Material Science KW - Computed Tomography KW - X-Ray KW - CT Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313380 ER - TY - JOUR A1 - Müller, Dominik A1 - Graetz, Jonas A1 - Balles, Andreas A1 - Stier, Simon A1 - Hanke, Randolf A1 - Fella, Christian T1 - Laboratory-Based Nano-Computed Tomography and Examples of Its Application in the Field of Materials Research JF - Crystals N2 - In a comprehensive study, we demonstrate the performance and typical application scenarios for laboratory-based nano-computed tomography in materials research on various samples. Specifically, we focus on a projection magnification system with a nano focus source. The imaging resolution is quantified with common 2D test structures and validated in 3D applications by means of the Fourier Shell Correlation. As representative application examples from nowadays material research, we show metallization processes in multilayer integrated circuits, aging in lithium battery electrodes, and volumetric of metallic sub-micrometer fillers of composites. Thus, the laboratory system provides the unique possibility to image non-destructively structures in the range of 170–190 nanometers, even for high-density materials. KW - nano CT KW - laboratory KW - X-ray KW - 3D reconstruction KW - instrumentation KW - integrated circuits KW - nondestructive testing KW - 3D X-ray microscopy Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-241048 SN - 2073-4352 VL - 11 IS - 6 ER - TY - JOUR A1 - Saussele, Susanne A1 - Hehlmann, Ruediger A1 - Fabarius, Alice A1 - Jeromin, Sabine A1 - Proetel, Ulrike A1 - Rinaldetti, Sebastien A1 - Kohlbrenner, Katharina A1 - Einsele, Hermann A1 - Falge, Christine A1 - Kanz, Lothar A1 - Neubauer, Andreas A1 - Kneba, Michael A1 - Stegelmann, Frank A1 - Pfreundschuh, Michael A1 - Waller, Cornelius F. A1 - Oppliger Leibundgut, Elisabeth A1 - Heim, Dominik A1 - Krause, Stefan W. A1 - Hofmann, Wolf-Karsten A1 - Hasford, Joerg A1 - Pfirrmann, Markus A1 - Müller, Martin C. A1 - Hochhaus, Andreas A1 - Lauseker, Michael T1 - Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV JF - Leukemia N2 - Major molecular remission (MMR) is an important therapy goal in chronic myeloid leukemia (CML). So far, MMR is not a failure criterion according to ELN management recommendation leading to uncertainties when to change therapy in CML patients not reaching MMR after 12 months. At monthly landmarks, for different molecular remission status Hazard ratios (HR) were estimated for patients registered to CML study IV who were divided in a learning and a validation sample. The minimum HR for MMR was found at 2.5 years with 0.28 (compared to patients without remission). In the validation sample, a significant advantage for progression-free survival (PFS) for patients in MMR could be detected (p-value 0.007). The optimal time to predict PFS in patients with MMR could be validated in an independent sample at 2.5 years. With our model we provide a suggestion when to define lack of MMR as therapy failure and thus treatment change should be considered. The optimal response time for 1% BCR-ABL at about 12-15 months was confirmed and for deep molecular remission no specific time point was detected. Nevertheless, it was demonstrated that the earlier the MMR is achieved the higher is the chance to attain deep molecular response later. KW - Chronic myeloid leukaemia KW - Molecularly targeted therapy KW - Risk factors KW - Risk factors KW - Translational research Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227528 VL - 32 IS - 5 ER - TY - JOUR A1 - Müller, Jörg A1 - Mitesser, Oliver A1 - Schaefer, H. Martin A1 - Seibold, Sebastian A1 - Busse, Annika A1 - Kriegel, Peter A1 - Rabl, Dominik A1 - Gelis, Rudy A1 - Arteaga, Alejandro A1 - Freile, Juan A1 - Leite, Gabriel Augusto A1 - de Melo, Tomaz Nascimento A1 - LeBien, Jack A1 - Campos-Cerqueira, Marconi A1 - Blüthgen, Nico A1 - Tremlett, Constance J. A1 - Böttger, Dennis A1 - Feldhaar, Heike A1 - Grella, Nina A1 - Falconí-López, Ana A1 - Donoso, David A. A1 - Moriniere, Jerome A1 - Buřivalová, Zuzana T1 - Soundscapes and deep learning enable tracking biodiversity recovery in tropical forests JF - Nature Communications N2 - Tropical forest recovery is fundamental to addressing the intertwined climate and biodiversity loss crises. While regenerating trees sequester carbon relatively quickly, the pace of biodiversity recovery remains contentious. Here, we use bioacoustics and metabarcoding to measure forest recovery post-agriculture in a global biodiversity hotspot in Ecuador. We show that the community composition, and not species richness, of vocalizing vertebrates identified by experts reflects the restoration gradient. Two automated measures – an acoustic index model and a bird community composition derived from an independently developed Convolutional Neural Network - correlated well with restoration (adj-R² = 0.62 and 0.69, respectively). Importantly, both measures reflected composition of non-vocalizing nocturnal insects identified via metabarcoding. We show that such automated monitoring tools, based on new technologies, can effectively monitor the success of forest recovery, using robust and reproducible data. KW - animal behaviour KW - conservation biology Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-358130 VL - 14 ER -